Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're looking into weight loss injections in or around Wakefield, the two medicines you'll encounter most often are tirzepatide (Mounjaro) and semaglutide (Wegovy). Both are prescription-only, once-weekly subcutaneous injections licensed in the UK for adults with a BMI of 30 or above, or from 27 with a qualifying weight-related condition. A prescriber decides suitability after a full clinical assessment — a pen cannot be dispensed without one. The good news: accessing a regulated service no longer means travelling anywhere. A GPhC-registered online pharmacy can review your consultation the same day and post treatment directly to your door in Wakefield.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear regularly is whether one injection is simply "better" than the other. The honest answer is that it depends on your health picture, not a league table. Tirzepatide works on two gut-hormone pathways simultaneously (GIP and GLP-1), making it the only dual-agonist weight-loss medicine licensed in the UK. Semaglutide targets the GLP-1 pathway alone. In clinical trials, the difference in average weight loss was real but modest at lower doses and wider at the highest ones, the SURMOUNT-1 trial data published in the New England Journal of Medicine showed tirzepatide achieving around 20–21% average reduction at 15mg over 72 weeks.
The choice isn't yours to make alone, and it shouldn't be. Your prescriber weighs contraindications, existing medicines, your history with GI symptoms, and whether you'd prefer a tablet over a pen. Semaglutide, for instance, is now also available as a once-daily oral tablet (Wegovy tablets) for those who'd rather skip injections altogether, you can read more on the weight loss injection overview if you want to compare formats before your consultation. A good consultation explores all of this. An algorithm doesn't.
One misconception worth letting go gently: that a higher dose always means faster results. The starting dose (2.5mg for tirzepatide, 0.25mg for semaglutide) exists primarily to let your system adjust. The prescriber advances the dose when it's clinically appropriate, not on a fixed calendar.
NHS access to weight loss injections is phased and tightly criteria-driven. As of June 2026, tirzepatide is available through GP practices in England for patients with a BMI of 40 or above plus four or more qualifying conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes). Cohort 2 (BMI 35–39.9 with four or more of those conditions) opened in late June 2026. Wegovy is available via specialist weight management services under NICE guidance TA875, but waiting lists at those services are commonly long. The weight loss injections Sheffield page covers the regional NHS picture in more detail if you want a broader Yorkshire-area view.
For people who don't meet the NHS thresholds yet, or simply can't wait, a regulated private service is the alternative. Private treatment means paying out of pocket, but it also means no waiting list, no referral needed, and a prescriber reviewing your case on the day you apply. What varies between private providers is safety infrastructure, not just price, and that gap matters enormously for a prescription medicine.
The MHRA has warned repeatedly about fake weight-loss pens sold online and through social media. Around 20 million doses of illegally traded weight-loss medicines (roughly £45m in street value) were seized in 2025 alone, and the first UK site producing counterfeit tirzepatide pens was raided in October 2025. Fake pens have in some cases contained insulin, the harm is not theoretical. The MHRA's Yellow Card scheme is where you can report suspect sellers or side effects; it's also worth reading their public guidance on GLP-1 medicines before purchasing anywhere.
Checking whether a pharmacy is legitimate takes about thirty seconds. The GPhC holds a public register of every registered pharmacy in the UK, you can verify nume's GPhC registration (9012878) directly on their site. Red flags include sellers offering these medicines without a prescription, prices dramatically below the private market, and discount codes attached to a prescription medicine. A guide to safely buying weight loss injections covers the full checklist if you want to go deeper.
For context on how private pricing works and what a transparent total cost should include, if you are also weighing up whether a hospital group is the right fit, the overview of Nuffield weight loss injections and the dedicated page on Nuffield Health weight loss injections set out what that route involves and how it compares to independent pharmacy provision.
Both injections are subcutaneous, into the fat layer just under the skin, not into a vein or muscle. The usual sites are the abdomen, outer thigh, or upper arm; rotating between them keeps the tissue healthy. Your pen must be stored in the fridge (2–8°C) until you're ready to use it, and the patient information leaflet gives the exact room-temperature window if you're travelling. Always refer to that leaflet for storage specifics rather than a third-party estimate.
Safe disposal matters too. Used pens are clinical waste, and NHS guidance is clear: they go into an approved sharps container, not a household bin. Your local council or GP surgery can advise on collection. Alcohol swabs, clean technique, and regular injection-site rotation are the unglamorous basics that make a real difference over months of treatment. The guide to the first three injections walks through the process if you'd like a step-by-step picture before you start.
If any of this raises questions specific to your health, our clinical team is there to answer them through the consultation, not after a delay, and not via a chatbot.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.